Prevalence and Genotype Distribution of Oncogenic-Risk Human Papilloma Virus in the Cervix of Climacteric Women with Normal Pap Smears

Miguel Ángel Olalla Herrera; Isabel María Jurado Navarrete; Rosario Moyano López; Susana Pérez Rodríguez; María Pilar Espejo Reina; María del Mar Olalla Jiménez

doi:10.4236/ojepi.2014.43022

Home > Journals > Medicine & Healthcare > OJEpi

Open Journal of Epidemiology > Vol.4 No.3, August 2014

Prevalence and Genotype Distribution of Oncogenic-Risk Human Papilloma Virus in the Cervix of Climacteric Women with Normal Pap Smears ()

Miguel Ángel Olalla Herrera, Isabel María Jurado Navarrete, Rosario Moyano López, Susana Pérez Rodríguez, María Pilar Espejo Reina, María del Mar Olalla Jiménez

.
LGT Unit, Gynaecology Department, V. de la Victoria University Hospital, Malaga, University of Malaga (UMA), Málaga, Spain.
The Unit of Lower Genital Tract (LGT) Pathology of the Department of Gynaecology, V. de la Victoria University Hospital, the University of Malaga (UMA), Málaga, Spain.

DOI: 10.4236/ojepi.2014.43022 PDF HTML 2,565 Downloads 3,311 Views Citations

Abstract

Objective: To find out the incidence of high-risk HPV infections on climacteric women within our area of influence; and to typify HPV genotypes on women with normal cytology that come to our hospitalary unit of menopausia. Material and Method: Cross-sectional study; with a random sample of 140 cases of climacteric women of ≥50 years of age, with normal Pap smears for the last 12 months. HPV determination was carried out by PCR for screening, and by hybrid capture for genotype typification. Results: The percentage of climacteric women who are carriers of oncogenic HPV and a normal Pap smear was of 11.43% (16/140 cases). The genotype found most frequently was HPV-16, followed by HPV-58, 51 and 18. Conclusions: We found a high prevalence of women who were carriers of oncogenic HPV in climacteric women with normal Pap smears (latent infections) in our health region. We consider that cervical cancer screening, either by PCR or conventional Pap smear, should not be minimized or ignored from 50 years of age onwards.

Keywords

Prevalence, Oncogenic Human Papilloma Virus, Climacteric

Share and Cite:

Herrera, M. , Navarrete, I. , López, R. , Rodríguez, S. , Reina, M. and Jiménez, M. (2014) Prevalence and Genotype Distribution of Oncogenic-Risk Human Papilloma Virus in the Cervix of Climacteric Women with Normal Pap Smears. Open Journal of Epidemiology, 4, 164-168. doi: 10.4236/ojepi.2014.43022.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	De Sanjosé, S., Diaz, M., Catellsague, X., Clifford, G., Bruni, L., Munoz, N. and Bosch, F.X. (2007) Worldwide Prevalence and Genotype Distributión of Cervical Human Papillomavirus DNA in Women with Normal Cytology: A Meta-Analysis. The Lancet Infectious Diseases, 7, 453-459. http://dx.doi.org/10.1016/S1473-3099(07)70158-5
[2]	Dunne, E.F., Unger, E.R., Sternberg, M., McQuillan, G., Swan, D.C., Patel, S.S., et al. (2007) Prevalence of HPV Infecctión among Femalesin the United States. JAMA, 297, 813-819. http://dx.doi.org/10.1001/jama.297.8.813
[3]	Parkin, D.M. (2006) The Global Health Burden of Infection-Associated Cancers in the Year 2002. International Journal of Cancer, 118, 3030-3044. http://dx.doi.org/10.1002/ijc.21731
[4]	Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J. and Shah, K.V. (2002) The Causal Relation between Human Papillomavirus and Cervical Cancer. Journal of Clinical Pathology, 55, 244-265. http://dx.doi.org/10.1136/jcp.55.4.244
[5]	Munoz, N., Castellsagué, X., Bernington, A. and Gissmann, L. (2006) HPV in the Etiology of Human Cáncer. Vaccine, 24, S 3/1-10.
[6]	Chesson, H.W., Blandford, J.M., Gift, T.L., Tao, G. and Irwin, K.L. (2004) The Estimated Direct Medical Cost of Sexually Trasmitted Disease among American Youth, 2000. Perspectives on Sexual and Reproductive Health, 36, 11-19. http://dx.doi.org/10.1363/3601104
[7]	Winer, R.L., Kiviat, N.B., Lee, S.K. and Hughes, J.P. (2005) Development and Duration of Human Papillomavirus Lesion, after Initial Infection. The Journal of Infectious Diseases, 191, 731-738. http://dx.doi.org/10.1086/427557
[8]	Franceschi, S., Herrero, R., Clifford, G.M., Rana, R.K. and Gallus, S. (2006) Variations in the Age-Specific Curves of Human Papillomavirus Prevalence in Women Worldwide. International Journal of Cancer, 119, 2677-2684.
[9]	WHO-ICO: HPV Information Centre. Sumary Reports. Update Year 2007. http://www.hpvcentre.net/summaryreport.php
[10]	Mo, L.Z., Monnier-Benoit, S. and Kantelip, B. (2007) Comparison of Amplicor and Hybrid Capture II. Genotyping Assay to Screen the Discordant Results. Journal of Clinical Virology, Nov.22.
[11]	Liu, J., Rose, B., Huang, X., Wang, C.J., Yen, C.F. and Lai, C.H. (2004) Comparative Analysis of Characteristics of Women with Cervical Cancer in High-Versis Low-Incidence Regions. Gynecologic Oncology, 94, 803-810. http://dx.doi.org/10.1016/j.ygyno.2004.06.005
[12]	Coupé, V.M.H., Berichof, J., Bullkmans, N.W.J., Snijders, P.I.F. and Maljer, C.J.L.M. (2008) Age-Dependent Prevalence of 14 H. Risk HPV Types in the Netherlands. British Journal of Cancer, 98, 646-651. http://dx.doi.org/10.1038/sj.bjc.6604162
[13]	Kumala, S.M.A., Shabalova, I.P., Petrovitchen, N., Syrjanem, K., Gyllensten, V.B., Syrjanem, S.M. and the NIS Study Group (2007) Prevalence of the Most Commón High-Risk HPV Genotipes among Women in Three New Independent States of the Former Soviet Unión. Journal of Medical Virology, 79, 771-781. http://dx.doi.org/10.1002/jmv.20839
[14]	Munoz, N., Bosch, F.X., De Sanjosé, S., Herrero, R., Castellsague, X., Shah, K.V., et al. (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. The New England Journal of Medicine, 348, 518-527. http://dx.doi.org/10.1056/NEJMoa021641
[15]	Bosch, F.X., Castellsagué, X., Cortés, J., Ptoré, L.M., Roura, E., De Sanjosé, S. and De Torné, A. (2009) Estudio Afrodita: Analisis de la conducta sexual, conocimiento causal del cancer de cervix y su prevención entre las mujeres espanolas. Edición G.S.K., Madrid, 37-53.
[16]	Fusté and Brull, P. (2008) Historia natural y oncogénesis del VPH. In: Oncológica, G., Ed., Ergón., Barcelona, 14.